Sex differences in 5-year risk of major adverse cardiovascular events in patients with coronary artery disease and elevated lipoprotein(a) levels

QR Code

Sex differences in 5-year risk of major adverse cardiovascular events in patients with coronary artery disease and elevated lipoprotein(a) levels

Aim. To evaluate 5-year major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) and high lipoprotein(a) (Lp(a)) levels in the Uzbek population.Material and methods. The study included 216 patients (96 men and 120 women) hospitalized with a diagnosis of "CAD. Pr...

Full description

Saved in:

Bibliographic Details
Main Authors:	R. B. Alieva, A. B. Shek, A. A. Abdullaev, H. G. Fozilov, Sh. U. Khoshimov, G. D. Abdullaeva, D. Zakirova, L. E. Kan, A. R. Kim, R. A. Kurbanova, D. B. Yusupalieva
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2025-04-01
Series:	Российский кардиологический журнал
Subjects:	high lipoprotein(a) level quantitative real-time pcr coronary artery disease major cardiovascular events sex differences
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/6019
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Low Serum Level of High-density Lipoprotein Cholesterol Is Associated with Gastric Cancer Regardless of Sex and Tumor Stage
by: Su Youn Nam, et al.
Published: (2022-09-01)

The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases
by: E. A. Utkina, et al.
Published: (2019-06-01)

Elevated levels of lipoprotein(a) and low-density lipoprotein cholesterol in familial hypercholesterolemia patients: is dual primary prevention already in sight?
by: Alpo Vuorio, et al.
Published: (2025-07-01)

LIPOPROTEIN APHERESIS: YESTERDAY, TODAY, TOMORROW. REVIEW
by: U. Julius, et al.
Published: (2018-09-01)

Elevated Lipoprotein(a) Predicts Stent Edge Restenosis and Adverse Two-Year Outcomes After PCI: An Intravascular Ultrasound Study
by: Wu X, et al.
Published: (2025-07-01)

VARIABILITY IN LEVELS OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DEPENDING ON AGE AND SEX AND ITS IMPORTANCE IN THE DIAGNOSIS OF THIS DISEASE
by: V. А. Korneva, et al.
Published: (2017-03-01)

BLOOD LIPOPROTEINS AS A PLATFORM FOR TRANSPORT OF HYDROPHILIC AND HYDROPHOBIC COMPOUNDS
by: L. M. Polyakov, et al.
Published: (2019-09-01)

High density lipoproteins of blood plasma as a transport form of actinomycin D
by: L. M. Polyakov, et al.
Published: (2019-01-01)

SPECIFICS OF SUBFRACTIONAL SPECTRUM OF APOLIPOPROTEIN B RELATED LIPOPROTEINES IN CAROTID OR CORONARY ATHEROSCLEROSIS PATIENTS
by: N. E. Gavrilova, et al.
Published: (2016-10-01)

Features and quantitative characteristics of the interaction of benzo[a]pyrene with fractions of the human blood plasma lipoproteins
by: L. M. Polyakov, et al.
Published: (2021-04-01)

DETECTION OF MODIFIED LIPOPROTEINS IN ATHEROSCLEROTIC LESIONS OF HUMAN AORTA
by: P. V. Pigarevsky, et al.
Published: (2014-07-01)

Uptake of cholesterol esters being a part of the different fractions of blood plasma lipoproteins by rats organs and tissues
by: L. M. Polyakov, et al.
Published: (2020-01-01)

Lipoprotein (a) integrates monocyte-mediated thrombosis and inflammation in atherosclerotic cardiovascular disease
by: Robert S. Rosenson, et al.
Published: (2025-06-01)

INFLUENCE OF NICOTINIC ACID ON SUBFRACTIONAL SPECTRUM OF LOW, INTERMEDIATE AND HIGH DENSITY LIPOPROTEINS IN PATIENTS WITH HYPERLIPOPROTEINEMIA(а)
by: E. A. Utkina, et al.
Published: (2017-06-01)

High Density Lipoproteins: Metabolism, Biological Functions and Risk of cardiovascular pathology
by: N. N. Smirnova, et al.
Published: (2023-12-01)

Impact of COVID-19 on pro- and antiatherogenic lipoproteins (cross-sectional population study)
by: P. S. Sadovnikov, et al.
Published: (2024-10-01)

Antibodies to low-density lipoproteins modified by malonic dialdehyde: contents in blood and role in atherogenesis
by: A. A. Ivanova, et al.
Published: (2025-01-01)

Lipoprotein(a), homocysteine and coronary atherosclerosis in young and middle-aged men
by: M. V. Ezhov, et al.
Published: (2008-10-01)

Elevated neutrophil to high-density lipoprotein ratio predicts pneumonia in patients with intracerebral hemorrhage
by: Yuning Feng, et al.
Published: (2025-07-01)

Demographics of lipoprotein(a) and stroke: The UK biobank
by: Andrew S. Kao, et al.
Published: (2025-09-01)

Hindlll polymorphism of lipoprotein lipase gene in patients with acute coronary syndrome
by: R. T. Saygitov, et al.
Published: (2008-12-01)

PROATHEROGENIC LIPID AND LIPOPROTEIN METABOLIC DISTURBANCES IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: E. V. Gerasimova, et al.
Published: (2017-07-01)

PHYSICO-CHEMICAL PROPERTIES OF RAT PLASMA LIPOPROTEINS: INFLUENCES OF SYMPATHETIC AND PARASYMPATHETIC LIVER DENERVATION, PARTIAL HEPATECTOMY AND INTRAPORTAL INTRODUCTION OF ATROPIN
by: N. S. Parfenova, et al.
Published: (2000-12-01)

Relationship of obesity, low-density lipoprotein cholesterol and myocardial perfusion in patients with risk factors and without atherosclerotic cardiovascular diseases
by: V. B. Sergienko, et al.
Published: (2021-03-01)

Sex and evolution /
by: Williams, George C., 1926-
Published: (1975)

LIPOPROTEIN(A) MEANING AS AN ADDITIONAL MARKER OF CARDIOVASCULAR RISK IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
by: V. A. Korneva, et al.
Published: (2016-06-01)

Genetics of sex differentiation /
by: Mittwoch, Ursula
Published: (1973)

Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and Sarcopenic obesity in U.S. adults: a cross-sectional study
by: Jiao Liu, et al.
Published: (2025-08-01)

Lipoprotein(a), atherosclerosis and cardiovascular risk
by: E. A. Polyakova, et al.
Published: (2024-12-01)

The sexes /
by: Carr, Donald Eaton
Published: (1970)

Lipoprotein transport and metabolism markers in patients with myocardial infarction in the Biobank of Yugra blood sample collection
by: A. S. Vorobyov, et al.
Published: (2025-01-01)

The peculiarities offish sex cycles and their ovary ripeness stages
by: N. I. Rabazanov, et al.
Published: (2015-01-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease: From a Very Low-Density Lipoprotein Perspective
by: Yan Chen, et al.
Published: (2025-07-01)

Association of Lipoprotein(a) With Major Adverse Limb Events and All‐Cause Mortality Following Revascularization for Chronic Limb‐Threatening Ischemia: A Substudy of the BEST‐CLI Trial
by: Alexander E. Sullivan, et al.
Published: (2025-06-01)

INFLUENCE OF CORTISOL AND VERY LOW-DENSITY LIPOPROTEINES ON THE DEVELOPMENT OF HA-1HEPATOMA AND EHRLICH’S CARCINOMA
by: L. E. Panin, et al.
Published: (2016-02-01)

Analysis of the low density lipoprotein receptor gene (<i>LDLR</i>) mutation spectrum in Russian familial hypercholesterolemia
by: V. B. Vasilyev, et al.
Published: (2022-06-01)

Serum albumin combined with high-density lipoprotein cholesterol as a novel marker to predict coronary heart disease: are their associations multiplicative or rateable?
by: Li He, et al.
Published: (2025-07-01)

Lipoprotein(a) in the diagnosis of cardiovascular risk. The values of lipoprotein (a) and apolipoprotein B in the adult population of Krasnoyarsk
by: V. S. Emelyanchik, et al.
Published: (2023-08-01)

Modification of blood lipoprotein and apolipoprotein levels by physical exercise of various type and intensity in healthy men with normo- and hyperlipidemia
by: M. G. Bubnova, et al.
Published: (2005-04-01)

Predictors of Major Adverse Cardiovascular Events in Stable Patients After ST Elevation Myocardial Infarction
by: Lidija Savic, et al.
Published: (2025-05-01)